Angiogenesis in metabolic-vascular disease

Area of Science:

• Vascular Biology
• Metabolic Diseases
• Endothelial Cell Biology

Background:

• Angiogenesis, the formation of new blood vessels, is vital for development but can become pathological in disease.
• In healthy adults, endothelial cells are quiescent, but disease states lead to dysfunction and hypoxia.
• Pathological angiogenesis is linked to cancer and diabetic retinopathy, and increasingly to metabolic diseases like obesity.

Purpose of the Study:

• To review the role of angiogenesis in metabolic-vascular diseases.
• To focus on angiogenesis in obesity-related metabolic dysfunction.
• To explore signaling pathways, like PI3K, that link endothelial cell metabolism to function.

Main Methods:

• Literature review of angiogenesis in metabolic diseases.
• Analysis of endothelial cell metabolism's role in angiogenesis.
• Examination of signaling pathways, including PI3K, in endothelial function.

Main Results:

• Deregulated angiogenesis is associated with adipose tissue dysfunction and insulin resistance in obesity.
• Endothelial cell metabolism significantly regulates angiogenesis.
• Signaling pathways, such as PI3K, influence endothelial metabolic activities and angiogenesis.

Conclusions:

• Angiogenesis plays a critical role in obesity-related metabolic dysfunction.
• Endothelial cell metabolism is a key regulator of angiogenesis in metabolic diseases.
• Targeting PI3K and related pathways may offer therapeutic strategies for metabolic-vascular diseases.